Document and Entity Information
Document and Entity Information | Oct. 26, 2020 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Oct. 26, 2020 |
Entity Registrant Name | ESSA Pharma Inc. |
Entity Central Index Key | 0001633932 |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Incorporation, State or Country Code | A1 |
Entity File Number | 001-37410 |
Entity Tax Identification Number | 47-2569713 |
Entity Address, Address Line One | Suite 720 |
Entity Address, Address Line Two | 999 West Broadway |
Entity Address, City or Town | Vancouver |
Entity Address, State or Province | BC |
Entity Address, Country | CA |
Entity Address, Postal Zip Code | V5Z 1K5 |
City Area Code | 778 |
Local Phone Number | 331-0962 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Shares, no par value |
Trading Symbol | EPIX |
Security Exchange Name | NASDAQ |